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Classical swine fever virus (CSFV) is the causative agent of classical swine fever. Its envelope comprises glycoproteins Erns, E1, and E2.
In this study, we showed that the unmodified CSFV glycoproteins could incorporate into the HIV core to generate an infectious CSFV
pseudotyped virus. The infection was specific to several porcine cell lines, and could be neutralized by anti-E2 monoclonal antibodies
(mAbs) completely and by anti-Erns mAbs partially, indicating that this pseudotyped virus can mimic the early infection steps of parental
CSFV. To investigate the specific role of each envelope protein involved in viral entry, a series of pseudotyped viruses were generated bearing
CSFV glycoproteins in various combinations. It was found that specific infectivity was also achieved with non-Erns pseudotyped virus
carrying E1 and E2 glycoproteins. This indicated that E1 and E2 are sufficient to mediate CSFV entry, and Erns is not indispensable in this
process.
D 2004 Elsevier Inc. All rights reserved.
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Classical swine fever (CSF) caused by the classical swine
fever virus (CSFV) is an important, highly contagious and
often fatal pig disease with widespread economic ramifica-
tions. CSFV belongs to the pestivirus genus within the
Flaviviridae family (van Regenmortel et al., 2000). It is an
enveloped, nonsegmented, positive-strand RNA virus
encoding three envelope glycoproteins: Erns (also named
E0), E1, and E2 (Rumenapf et al., 1993; Weiland et al.,
1990; Wensvoort et al., 1990). E1 and E2 have trans-
membrane domains. They can be present as an E1–E2
heterodimer, and also as an E2–E2 homodimer, by disulfide
linkage (Weiland et al., 1990; Wensvoort et al., 1990). Erns0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to the article.lacks the membrane anchor and is secreted from infected
cells (Rumenapf et al., 1993). It can also associate with
virions by an as yet unknown mechanism (Weiland et al.,
1992).
E2 and Erns have been reported to be involved in CSFV
entry (Hulst and Moormann, 1997), but their exact functions
in this process are still unclear. E2 is the major neutralizing
antigen for CSFV infection (Greiser-Wilke et al., 1990;
Rumenapf et al., 1993), while Erns is considered the second
glycoprotein that mediates neutralization (Weiland et al.,
1992). However, because of the low titer of CSFV in cell
cultures and the inherent obstacles in traditional virus entry
assays, the details concerning the CSFV entry mechanism
remain obscure. Therefore, a specific and sensitive CSFV
entry assay is required to separate viral entry and post-entry
stages, and to dissect the function of each glycoprotein in
this process.
Retroviral pseudotyped viruses have been widely used
to study viral entry, because retroviruses can incorporate
heterologous virus envelope proteins into their lipid
membranes and acquire the host range of the virus from04) 332–341
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et al., 2003b; Dong et al., 1992; Hsu et al., 2003; Landau
et al., 1991; Suomalainen and Garoff, 1994). Furthermore,
the pseudotyped viruses only undergo a single-cycle
infection and carry a reporter gene, thus facilitating
quantitative assays. In this study, we incorporated
unmodified CSFV glycoproteins into the HIV core to
generate infectious CSFV pseudotypes, and showed that
their infection could be neutralized by anti-E2 mAbs
completely and by anti-Erns mAbs partially. Moreover,
specific infectivity could be achieved with non-Erns
pseudotypes carrying E1 and E2, indicating that E1 and
E2 are sufficient to mediate CSFV entry, and Erns is not
indispensable in this process.Results
Infectious CSFV pseudotyped particles can be assembled in
vitro
The CSFV genomic RNA is translated into a polyprotein
that is cleaved into a number of proteins by the host cells
and virus-encoded proteases. A glycoprotein precursor
Erns12 is formed, which is processed into Erns, E1, and E2
(Rumenapf et al., 1993). During this process, the C terminus
of the C protein serves as a signal peptide for CSFV
glycoproteins and is recognized by signalase, which causes
a nascent cleavage between the C protein and the trans-
located Erns12. Therefore, for the expression of CSFV Erns,
E1, and E2 glycoproteins, the putative internal signal
sequence localized immediately upstream of the Erns N
terminus was included. While the exact start of this signal
peptide is unknown, we reserved 60aa of the C terminus ofFig. 1. CSFV ErnsE1E2 expression constructs. A cDNA derived from the CSFV
individually or in different combinations. The C terminus of the C protein, which n
SP for each construct. TMD: transmembrane domain.the core protein containing the signal peptide for Erns, E1,
and E2 (Fig. 1)—a similar strategy was also used for the
generation of HCV pseudotyped viruses (Bartosch et al.,
2003b).
The Erns12 gene was cloned into pcDNA3.1(+) under
control of the cytomegalovirus immediate–early promoter
(pErns12). The polyprotein was expressed by transient
transfection in 293T cells. We first detected the cell surface
expression of CSFV glycoproteins, as HIV budding and
incorporation of glycoproteins occurred at this place. CSFV
Erns was reported to be located on the cell surface, while E2
was located in the endoplasmic reticulum and was not
targeted to the cell surface. But when overexpression of E2
occurred, cell surface expression of this glycoprotein could
be detected (Konig et al., 1995; Rumenapf et al., 1993;
Thiel et al., 1991; Weiland et al., 1999). Our flow cytometric
analysis (Fig. 2) demonstrated that both Erns and E2 proteins
could be detected on the cell surface. E2 dimmer formation
was examined by using a nonreduced immunoblot assay
(Rumenapf et al., 1991; Weiland et al., 1990). The apparent
band with molecular mass of approximately 75 kDa
corresponded to the E1–E2 heterodimers (Fig. 3A), while
the E2–E2 homodimers were about 100 kDa and could also
be detected (Rumenapf et al., 1991; Wensvoort et al., 1990).
HIV p24 as a control could also be detected in the virus
pellet (Fig. 3B).
To produce the CSFV pseudotyped virus, 293T cells
were co-transfected with the plasmid pNL4.3.Luc.
REpro encoding an envelope-defective HIV-1 proviral
genome with a luciferase reporter gene (Connor et al.,
1995), and pErns12 encoding CSFV glycoproteins. Controls
were generated with the pcDNA3.1 (+) vector or with
plasmid encoding VSV G. Pseudotyped particles were
purified from supernatants by ultracentrifugation throughpolyprotein gene was used to express the Erns, E1, and E2 glycoproteins
atively provides the signal peptide (SP) for Erns, was here used to provide the
Fig. 2. Detection of CSFV Erns and E2 expression on the cell surface by flow cytometry. 293T cells were transfected with pErns12. Forty-eight hours after
transfection, cells were stained with anti-Erns mAbs 140.1 (A) or anti-E2 mAbs V3 (B), respectively (shaded shape). Cells transfected with pcDNA3.1 (+)
vector were used as negative controls (open shape).
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the nonreduced immunoblot. As shown in Fig. 3B, a 75-kDa
band representing CSFV E1–E2 heterodimers could be
detected, indicating they can incorporate into HIV cores.
To test if the pseudotyped virus bearing CSFV Erns12
(termed HIV/Erns12) was infectious, PK15 cells were
incubated with supernatants containing the pseudotyped
virus (5 ng per well p24) for 3 h, and the luciferase activity
of the cell lysates was tested 48 h later. It was found that
HIV/Erns12 was infectious to PK15 (Fig. 4A). The tropism
of HIV/Erns12 was then investigated on a panel of target cell
lines derived from swine, mouse, hamster, canine, monkey,
and human. We found that only swine cell lines PK15, LLC-
PK1, SK6, MPK, and ST could be infected by HIV/Erns12,and among these cell lines we detected the highest
infectivity occurred on PK15 cells (Fig. 4A). HIV/VSV G
was used as a positive control and could infect all cell lines.
These data indicated that the infectious CSFV pseudotyped
virus can be assembled in vitro, and its tropism restricts to
swine cell lines, as previously reported with the wild-type
CSFV (Carbrey et al., 1976).
CSFV pseudotyped virus can be neutralized by anti-E2 and
anti-Erns mAbs
To further ascertain whether the specific infectivity of
CSFV pseudotyped virus was mediated by CSFV glyco-
proteins, two anti-Erns mAbs (24/16, 140.1) and two anti-E2
Fig. 3. Western blotting analysis of E2 expression from transfected cells and
purified pseudotyped viral particles. (A) 293T cells were transfected with
expression constructs (E2, Erns plus E2, E12, Erns12). After 48 h, cell
lysates were separated under 10% nonreduced SDS-PAGE, and blotted with
anti-E2 mAb a18. 293T cells transfected with pcDNA3.1 (+) vector were
used as negative controls. (B) Pseudotyped viruses bearing CSFV
glycoproteins in various combinations (E2, Erns plus E2, E12, Erns12) were
purified through 20% sucrose cushions. Pellet samples were submitted to
run 10% nonreduced SDS-PAGE and blotted with anti-E2 mAb a18 or HIV
p24 antiserum as a control. Empty HIV cores with no glycoprotein provided
were used as negative controls.
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infection of HIV/Erns12 on PK15 cells. The antibody anti-
p125 against the nonstructural protein NS3 was used as a
negative control. We found both of the two anti-E2 mAbs
showed more than 95% neutralizing ability at 5 Ag/ml, while
both of the two anti-Erns mAbs showed weak neutralizing
ability against HIV/Erns12 infection at a higher concen-
tration of 20 Ag/ml (Fig. 4B).CSFV pseudotyped virus entry is inhibited by NH4Cl
To assess whether the CSFV pseudotyped virus entry is
pH-dependent (Flores et al., 1996), we treated PK15 cells
with well-characterized lysosomotropic agent NH4Cl.
Exposure of cells to NH4Cl prevents endosomal acid-
ification, thus blocking the pH-dependent fusion between
the virus envelope and the intracellular endosomal mem-
brane (Sieczkarski and Whittaker, 2002). HIV bearing VSV
G and amphotropic murine leukemia virus (AMLV)
glycoprotein were used as controls, which demonstrated
pH-dependent and pH-independent routes of entry, respec-
tively. Treatment with 20 mM NH4Cl caused N90%
inhibition of infection by HIV/VSV G or HIV/Erns12,
while no inhibition could be detected with AMLV
pseudotyped virus (Fig. 5). These data indicated the HIV/
Erns12’s entry may be pH-dependent.
Infectious CSFV pseudotyped virus can be generated
without Erns
To study the specific role of each CSFV glycoprotein in
pseudotyped virus entry, a series of expression plasmids
were constructed, encoding Erns, E1, E2, Erns1, and E12,
respectively (Fig. 1). These plasmids allowed us to generate
various pseudotyped viruses bearing CSFV glycoproteins in
various combinations. We checked the expression of
glycoprotein E2 in cell lysates, and also in pseudotyped
viruses with HIV p24 detection as a control. As shown in
Western blots (Figs. 3A,B), when E2 was expressed without
E1, it strongly formed a homodimer of about 100 kDa; and
when matured from the polyprotein Erns12 or E12, the E1–
E2 heterodimer, at about 75 kDa, was the major form that
could be detected.
We then tested the infectivity of these pseudotyped
viruses on PK15 cells. Besides pseudotypes bearing Erns,
E1, and E2, we found pseudotyped virus bearing E1 and E2
could also achieve high infectivity, especially when matured
from E12 (termed HIV/E12), while other pseudotyped
viruses had no infectivity (Fig. 6A). Further experiments
were performed to investigate the entry characteristics of
HIV/E12. We found its tropism was also restricted to
porcine cell lines (Fig. 4A); the infection could be inhibited
by NH4Cl (Fig. 5), and could be completely neutralized by
anti-E2 mAbs (a18 and V3) at the concentration of 5 Ag/ml
(Fig. 6B). All of these characteristics were similar to that of
HIV/Erns12. These data indicated that CSFV E1 and E2 are
sufficient to mediate pseudotyped virus entry, and Erns is not
indispensable in this process.
We found that the infectivity of HIV/E12 was lower than
HIV/Erns12 on all cell lines tested (Fig. 4A). One possible
impact factor was the low expression level of CSFV
glycoproteins in 293T cells transfected with pE12. As
shown in Fig. 3, the expression level of CSFV glycoproteins
in 293T cells transfected with pE12 was lower than that of
293T cells transfected with pErns12 (Fig. 3A), and a similar
Fig. 4. Specific infection of CSFV pseudotyped viruses. (A) Infectivity of CSFV pseudotypes on different cell types. The results of infection were shown by
average of luciferase activity (CPS) of triplicate determinations. (B) Neutralization of CSFV pseudotypes’ infectivity. MAbs at concentrations of 20, 10, and
5 Ag/ml were used to neutralize CSFV pseudotypes infection on PK15 cells. MAb anti-p125 specific to a nonstructural protein NS3 of CSFV was used as a
negative control. Neutralization was determined by inhibition of luciferase activity. Similar results were obtained in two independent experiments.
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particles (Fig. 3B).
Another reason may be the lack of Erns that lead to lower
infectivity. However, providing Erns in trans with E12 did
not assist in improving of the infectivity of the pseudotyped
virus, but actually lead to lower infectivity (Fig. 6A).
Similarly, pseudotypes bearing E1 and E2 matured from
pE1 and pE2 in trans also lead to lower infectivity than
those matured from pE12 in cis. These data suggested the
expression and maturation pattern of CSFV glycoproteins
might have an impact on protein functions.
CSFV glycoproteins can induce cell–cell fusion
To further ascertain if the CSFV glycoproteins function
in the membrane fusion process, we tested their ability bycell–cell fusion assay because the fusion between cells
expressing virus glycoproteins and the susceptible cells
could mimic the virus–cell fusion process. 293T cells were
transiently transfected with Erns12, E12, E2 expression
constructs, and then mixed and cultured with PK15 cells. As
we previously found the CSFV entry might be a pH-
dependent process, in this cell–cell fusion experiment, the
cocultured cells were treated with PBS at pH 5.5 for 2 min
and then cultured normally. Syncytia formation was checked
under microscope 6 h post acidification. Cells containing
more than five nuclei were considered typical syncytia. As
shown in Fig. 7, Erns12 could induce syncytia formation.
E12 also induced fewer numbers of syncytia formation.
293T cells transfected with E2 alone and pcDNA3.1 (+)
vector as a negative control showed no syncytium formation
with PK15 cells. We also did this experiment at neutral pH,
Fig. 5. pH dependency of CSFV pseudotypes infectivity. PK15 cells treated with various concentrations of NH4Cl were infected with 5 ng (p24) of each
pseudotyped virus. The infectivity was determined at 48 h post infection based on the luciferase activity. The luciferase activity from 0 mM NH4Cl-treated cells
was taken as 100%.
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shown). We also found that neither PK15 nor 293T
expressing CSFV glycoproteins could solely form syncy-
tium, either in a neutral pH or after acidification (data not
shown). These results indicated that acidic environment
strongly promotes membrane fusion mediated by CSFV
glycoproteins, and E1 and E2 are sufficient to mediate this
process.Discussion
In this study, we demonstrated that unmodified CSFV
glycoproteins matured from the polyprotein Erns12 of
CSFV could incorporate into the retroviral core to generate
an infectious pseudotyped virus. The infection of pseudo-
typed virus was specific for several types of porcine cell
lines, including PK15, LLC-PK1, SK6, MPK, and ST
cells, which was consistent with wild-type virus infection
(Carbrey et al., 1976). Because the CSFV glycoproteins we
used were derived from cF114 strain, which was propa-
gated on PK15 cells (Nie et al., 2003), it was reasonable to
detect that PK15 cells exhibited the highest susceptibility
among the tested porcine cell lines. This CSFV pseudo-
typed virus can be completely neutralized by anti-E2
mAbs, while anti-Erns mAbs also show a partial neutraliz-
ing ability. These findings were consistent with previous
studies that showed E2 to be the major target for
neutralizing antibodies, and Erns is the second envelope
protein mediating neutralization (Greiser-Wilke et al.,
1990; Weiland et al., 1992). Thus, we established, for
the first time, a specific, reliable, and sensitive in vitro
pseudotyped virus assay for CSFV research, which may
further reveal the entry mechanism of the parental virus.Furthermore, this assay can be used for testing anti-CSFV
neutralizing antibodies, evaluating CSFV vaccines, and
mapping neutralizing epitopes within envelope proteins
(Bartosch et al., 2003a). Within the Flaviviridae family,
although several putative receptors were identified as virus
receptors (Agnello et al., 1999; Maurer et al., 2004; Pileri
et al., 1998), expressing these molecules alone does not
permit effective infection. Our CSFV pseudotypes thus can
facilitate receptor identification.
We demonstrated that, as a representative pestivirus, the
infectivity of CSFV pseudotyped virus may be pH-depend-
ent, as it could be inhibited by an endosomal pH acid-
ification inhibitor. This indicated that CSFV enters cells
through a receptor-mediated endocytic route, while the
fusion function of the virus glycoprotein is activated by
acidification of the virion environment (Sieczkarski and
Whittaker, 2002). Within the Flaviviridae family, flavivirus
and hepatitis C virus (HCV) pseudotyped particles were
proved to exhibit pH dependency when entering cells
(Bartosch et al., 2003c; Gollins and Porterfield, 1985,
1986; Heinz and Allison, 2001; Heinz et al., 1994; Hsu et
al., 2003). CSFV as a representative of pestivirus shares the
same characteristics as them, therefore suggesting that the
members within the Flaviviridae family may use a similar
cell entry mechanism.
Our experiments with pseudotyped viruses bearing
various combinations of CSFV glycoproteins showed that,
besides the parent-like CSFV pseudotyped virus HIV/
Erns12, non-Erns pseudotyped virus HIV/E12 bearing only
E1 and E2 was also infectious. Furthermore, the tropism of
HIV/E12 was identical to that of HIV/Erns12. Its infectivity
could be inhibited by NH4Cl, and could be completely
neutralized by anti-E2 mAbs. These all indicated E1 and E2
are sufficient to mediate CSFV entry.
Fig. 6. Infectious CSFV pseudotyped virus can be generated without Erns. (A) Pseudotyped viruses were generated from CSFV glycoproteins in various
combinations and their infectivity was test on PK15 cells. Pseudotypes generated with VSV G and with no glycoprotein were used as positive and negative
controls, respectively. (B) Neutralization assay of HIV/E12. Anti-E2 mAbs a18 and V3 at concentration of 20, 10, and 5 Ag/ml were used to neutralize HIV/
E12 infection on PK15 cells. MAb anti-p125 specific to a nonstructural protein NS3 of CSFV was used as a negative control. Neutralization was determined by
inhibition of luciferase activity.
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cell–cell fusion assay. 293T cells transfected with pErns12 or
pE12 could induce syncytia formation between PK15 cells
with acid pH treatment, while E2 alone could not, indicating
E1 and E2 are sufficient in the membrane fusion process,
and an acidic environment can promote this process. As
only part of CSFV glycoproteins were leaked to the cell
membrane in this overexpression system, it was reasonable
that the syncytia we detected were few and small.
It has been reported that E2 can form E1–E2 hetero-
dimers with E1, and E2–E2 homodimers, which are present
in both virions and cells infected with CSFV (Thiel et al.,
1991; Weiland et al., 1990; Wensvoort et al., 1990).
However, it is still unknown which form of E2 is functional
during viral entry. In our experiments, we found that in
pseudotypes bearing E2, or Erns plus E2, only the E2–E2homodimers could be detected, and these pseudotypes had
no infectivity. This suggested that E2–E2 homodimers may
not be the functional form of E2 during viral entry. While in
the infectious HIV/E12 and HIV/Erns12, E1–E2 heterodimer
was the major form of E2 as we detected. These data
suggested that the E1–E2 heterodimer, rather than the E2–
E2 homodimer, may be the functional form during viral
entry.
Our findings with infectious HIV/E12 also demonstrated
that Erns is not indispensable during viral entry. In fact, Erns
may take part in the initial attachment process of viral entry,
rather than in the specific binding or fusion process. First,
the previous report that Erns can also bind to CSFV
noninfected cells suggests that Erns interacts with a widely
expressed surface molecule (Hulst and Moormann, 1997).
Second, Erns can bind to the mannose 6-phosphate receptor
Fig. 7. Syncytium formation between PK15 cells and CSFV glycoproteins transfected 293T cells. 293T cells transfected with pErns12, pE12, pE2, or pcDNA3.1
(+) vector were trypsinized 36 h later and cocultured with PK15 at the ratio of 1:1 for 12 h. The cocultured cells were bathed in PBS at pH 5.5 for 2 min at 37 8C
and then incubated with DMEM containing 10% FBS. The syncytia were observed 6 h later under microscope.
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Third, CSFV with a mutant Erns could enter cells through a
heparin sulfate-dependent route (Hulst et al., 2000, 2001).
Fourth, as we showed, mAbs against Erns could not
completely neutralize CSFV pseudotyped virus infection.
Based on these facts, we proposed that Erns interacts with a
cell surface molecular as an initial attachment, which can
facilitate the virus entry but the function is not decisive.
Moreover, Erns was found to contain RNase activity (Hulst
et al., 1994; Schneider et al., 1993), and can induce cell
apoptosis in lymphocytes of several species (Bruschke et al.,
1997). These facts suggest that Erns may also play an
important role in the post-entry stages, which may be a
possible reason causing the CSFV with Erns deletion to be
nontransmissible as reported (Widjojoatmodjo et al., 2000).Materials and methods
Cells
Porcine cell lines PK15, ST, LLC-PK1, and SK6; human
cell lines 293T and Hela; monkey cell lines VeroE6 and
COS7; mouse cell line NIH/3T3; hamster cell line BHK21;
and canine cell line MDCK were grown in DMEM
containing 10% FBS. Mini-pig cell line MPK was grown
in DMEM containing 20% FBS.Plasmids
Plasmids pErns, pErns1 and pErns12 (Fig. 1) encoding Erns
(polyprotein residues 208–494), Erns1 (polyprotein residues
208–689), and Erns12 (polyprotein residues 208–1065)
glycoproteins were constructed by insertion into pcDNA3.1
(+) a DNA fragment encoding the last 60 residues of CSFV
C protein and Erns, Erns1, and Erns12 glycoproteins that were
amplified by PCR from pMC12297 plasmid (Nie et al.,
2003), a construct containing the full-length cDNA of cF114
strain (F114 strain propagated on PK15 cells).
Plasmids pE1, pE12, and pE2 (Fig. 1) encoding E1, E12,
and E2 glycoproteins were constructed by fusing the DNA
fragment encoding the last 60 residues of CSFV C protein
(208–267) and the fragments encoding E1 (polyprotein
residues 495–689), E12 (polyprotein residues 495–1065),
and E2 (polyprotein residues 690–1065) glycoproteins
amplified from pMC12297 by overlapping PCR.
Antibodies
Anti-E2 mAb a18 (Weiland et al., 1990), anti-Erns mAb
24/16 (Weiland et al., 1992), and mAb anti-p125 were
generously provided by Dr. R.J.M. Moormann, Institute
for Animal Science and Health, the Netherlands. Anti-E2
mAb V3, and anti-Erns mAb 140.1 were purchased from
CEDI-Diagnostics, the Netherlands. HIV p24 antiserum
Z. Wang et al. / Virology 330 (2004) 332–341340was generously provided by Dr. Yiming Shao at China
CDC.
Flow cytometric analysis
293T cells in 10-cm dishes were transfected with pErns12
(20 Ag) and collected 48 h later. The cells were washed with
PBS, and then incubated with anti-Erns mAb 140.1 or anti-
E2 mAb V3 for 1 h. After washing with PBS, the cells were
incubated with FITC conjugated rabbit anti-mouse IgG
(Sigma) for 30 min. Finally, the cells were analyzed by a
flow cytometer (MoFlo High-Performance Cell Sorter,
Dako Cytomation).
Preparation of pseudotyped viruses
The pseudotyped virus was prepared as previously
described (Deng et al., 1996). Briefly, 293T cells were
transfected with 10 Ag plasmids expressing the viral
glycoproteins or pcDNA3.1 (+) vector, and 10 Ag enve-
lope-defective pNL4.3.Luc.REpro (Connor et al., 1995)
viral genome using the calcium phosphate transfection
method (Deng et al., 1996). The medium was replaced 12 h
after transfection. Supernatants were harvested 36 h later and
centrifuged at 3000 g for 10 min to remove the cell debris;
these were then used in infection assays. HIV p24 antigen
content was assessed by using a commercially available EIA
(Beckman Coulter).
Western blotting assays
293T cells were transfected with CSFV glycoprotein
expression constructs. After 48 h, the cells were collected.
Pseudotyped viruses prepared as described above were
purified by ultracentrifugation of 10-ml viral supernatants
through a 2 ml 20% sucrose cushion in a SW 41 Beckman
rotor (50000  g, 1.5 h, 4 8C). Fractions were resuspended
in 100 Al PBS, and HIV p24 was measured as described
above. Transfected cells, or purified viral pellets, were
diluted with 2% SDS without reducing reagents and were
heat-denatured. Lysates of 105 cells, or 10 ng purified viral
particles each lane were subsequently separated by 10%
SDS-PAGE (Schagger and von Jagow, 1987). The proteins
were transferred onto nitrocellulose membranes and under-
went immunostaining. Anti-E2 mAb a18 or HIV p24
antiserum was used as the primary antibody. Goat anti-mice
IgG labeled with alkaline phosphatase was used as
secondary antibody.
Infection assays
Target cells were distributed to a 24-well plate (6  104
cells/well). After 24 h, cells were incubated with supernatant
containing 5 ng pseudotyped virus (p24) and 4 Ag/ml
polybrene per well for 3 h. The supernatants were removed
and the cells were incubated in fresh medium at 37 8C foranother 48 h, washed in PBS once, and lysed with 100 Al
lysis buffer (Promega). Twenty microliters of lysate was
tested for luciferase activity by the addition of 50 Al of
luciferase substrate, and was measured for 10 s in a Wallac
Multilabel 1450 Counter (Perkin Elmer).
For neutralization assays, mAbs specific for Erns (24/16,
140.1) or E2 (a8, V3) at concentrations of 20, 10, and 5 Ag/
ml were incubated with pseudotyped viruses for 30 min at
37 8C, and the mixtures were tested for infectivity on PK15
cells as described above.
The pH dependency of infection was evaluated by
pretreating PK15 cells for 1 h with serum-free DMEM
containing ammonium chloride at various concentrations
(0–20 mM) at 37 8C; this was followed by incubation with
supernatants containing the pseudotyped viruses in the
presence of ammonium chloride at the consistent concen-
tration as in the pretreating procedure. After 3 h, the
supernatants were replaced with DMEM containing 10%
FBS. The luciferase activity was determined 48 h later as
described above.
Cell–cell fusion assay
293T cells were transfected with pErns12, pE12, pE2, or
pcDNA3.1 (+) vector. Thirty-six hours after transfection,
293T cells were trypsinized and mixed with PK15 at a ratio
of 1:1 for 12 h. The cocultured cells were bathed in PBS at
pH 5.5 for 2 min at 37 8C and then incubated with DMEM
containing 10% FBS. Six hours later, the syncytia were
examined under microscope.Acknowledgments
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